|
1
|
Chen HM, Zhang P, Voso MT, et al:
Neutrophils and monocytes express high levels of PU.1 (Spi-1) but
not Spi-B. Blood. 85:2918–2928. 1995.PubMed/NCBI
|
|
2
|
Rosenbauer F, Wagner K, Kutok JL, et al:
Acute myeloid leukemia induced by graded reduction of a
lineage-specific transcription factor, PU.1. Nat Genet. 36:624–630.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pettersson M, Sundstrom C, Nilsson K and
Larsson LG: The hematopoietic transcription factor PU.1 is
downregulated in human multiple myeloma cell lines. Blood.
86:2747–2753. 1995.PubMed/NCBI
|
|
4
|
Sokalski KM, Li SK, Welch I, Cadieux-Pitre
HA, Gruca MR and DeKoter RP: Deletion of genes encoding PU.1 and
Spi-B in B cells impairs differentiation and induces pre-B cell
acute lymphoblastic leukemia. Blood. 118:2801–2808. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kihara-Negishi F, Suzuki M, Yamada T,
Sakurai T and Oikawa T: Impaired repressor activity and biological
functions of PU.1 in MEL cells induced by mutations in the
acetylation motifs within the ETS domain. Biochem Biophys Res
Commun. 335:477–484. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aoyama S, Nakano H, Danbara M, Higashihara
M, Harigae H and Takahashi S: The differentiating and apoptotic
effects of 2-aza-5′-deoxycytidine are dependent on the PU.1
expression level in PU.1-transgenic K562 cells. Biochem Biophys Res
Commun. 420:775–781. 2012.PubMed/NCBI
|
|
7
|
Woessmann W, Zwanzger D and Borkhardt A:
ERK signaling pathway is differentially involved in erythroid
differentiation of K562 cells depending on time and the inducing
agent. Cell Biol Int. 28:403–410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sztiller-Sikorska M, Jakubowska J, Wozniak
M, Stasiak M and Czyz M: A non-apoptotic function of caspase-3 in
pharmacologically-induced differentiation of K562 cells. Br J
Pharmacol. 157:1451–1462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iseki Y, Imoto A, Okazaki T, Harigae H and
Takahashi S: Identification of annexin 1 as a PU.1 target gene in
leukemia cells. Leuk Res. 33:1658–1663. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Imoto A, Okada M, Okazaki T, Kitasato H,
Harigae H and Takahashi S: Metallothionein-1 isoforms and vimentin
are direct PU.1 downstream target genes in leukemia cells. J Biol
Chem. 285:10300–10309. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iseki Y, Nakahara M, Kubo M, Obata F,
Harigae H and Takahashi S: Correlation of PU.1 and signal
regulatory protein α1 expression in PU.1 transgenic K562 cells. Int
J Mol Med. 29:319–323. 2012.PubMed/NCBI
|
|
12
|
Takahashi S, Harigae H, Kameoka J, Sasaki
T and Kaku M: AML1B transcriptional repressor function is impaired
by the Flt3 internal tandem duplication. Br J Haematol.
130:428–436. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rao G, Rekhtman N, Cheng G, Krasikov T and
Skoultchi AI: Deregulated expression of the PU.1 transcription
factor blocks murine erythroleukemia cell terminal differentiation.
Oncogene. 14:123–131. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamada T, Kondoh N, Matsumoto M, Yoshida
M, Maekawa A and Oikawa T: Overexpression of PU.1 induces growth
and differentiation inhibition and apoptotic cell death in murine
erythroleukemia cells. Blood. 89:1383–1393. 1997.PubMed/NCBI
|
|
15
|
Yamada T, Abe M, Higashi T, et al: Lineage
switch induced by overexpression of Ets family transcription factor
PU.1 in murine erythroleukemia cells. Blood. 97:2300–2307. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Back J, Dierich A, Bronn C, Kastner P and
Chan S: PU.1 determines the self-renewal capacity of erythroid
progenitor cells. Blood. 103:3615–3623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wontakal SN, Guo X, Will B, et al: A large
gene network in immature erythroid cells is controlled by the
myeloid and B cell transcriptional regulator PU.1. PLoS Genet.
7:e10013922011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takahashi S: Opposing role, depending on
the stage, of PU.1 during erythroid differentiation. J Blood Lymph.
2:e1082012. View Article : Google Scholar
|
|
19
|
Donze D, Townes TM and Bieker JJ: Role of
erythroid Kruppel-like factor in human gamma- to beta-globin gene
switching. J Biol Chem. 270:1955–1959. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wall L, Destroismaisons N, Delvoye N and
Guy LG: CAAT/enhancer-binding proteins are involved in beta-globin
gene expression and are differentially expressed in murine
erythroleukemia and K562 cells. J Biol Chem. 271:16477–16484. 1996.
View Article : Google Scholar : PubMed/NCBI
|
